Finally, NDFIP2 gene expression has been shown to be significantly decreased in acute myeloid leukemia (AML) patients in a study that reported a strong correlation between high ifitm3 expression and adverse prognosis in infected AML patients [41]. This evidence concerns the gene IFITM3 and acute myeloid leukemia.